Astroglial Connexin 43-Mediated Gap Junctions and Hemichannels: Potential Antidepressant Mechanisms and the Link to Neuroinflammation

• Published in: Cellular and molecular neurobiology 2023-11, Vol.43 (8), p.4023-4040
• Main Authors: Lei, Lan, Wang, Ya-Ting, Hu, Die, Gai, Cong, Zhang, Yi
• Format: Article
• Language: English
• Subjects: Antidepressants; Antidepressive Agents - metabolism; Antidepressive Agents - pharmacology; Antidepressive Agents - therapeutic use; Astrocytes; Astrocytes - metabolism; Biomedical and Life Sciences; Biomedicine; Brain-derived neurotrophic factor; Cell Biology; Connexin 43; Connexin 43 - metabolism; Drug delivery; Excitotoxicity; Gap junctions; Gap Junctions - metabolism; Glutamic acid receptors; Humans; Hypothalamic-pituitary-adrenal axis; Hypothalamo-Hypophyseal System - metabolism; Inflammation; Mental depression; Mental disorders; N-Methyl-D-aspartic acid receptors; Neurobiology; Neuroinflammatory Diseases; Neurosciences; Pathology; Pituitary-Adrenal System - metabolism; Psychotropic drugs; Review Paper; Suicide
• ISSN: 0272-4340; 1573-6830
• DOI: 10.1007/s10571-023-01426-5

Major depression disorder (MDD) is a neuropsychiatric disorder associated with a high suicide rate and a higher disability rate than any other disease. Evidence suggests that the pathological mechanism of MDD is related to astrocyte dysfunction. Depression is mainly associated with the expression of connexin 43 (Cx43) and the function of Cx43-mediated gap junctions and hemichannels in astrocytes. Moreover, neuroinflammation has been a hotspot in research on the pathology of depression, and Cx43-mediated functions are thought to be involved in neuroinflammation-related depression. However, the specific mechanism of Cx43-mediated functions in neuroinflammation-related depression pathology remains unclear. Therefore, this review summarizes and discusses Cx43 expression, the role of gap junction intercellular communication, and its relationship with neuroinflammation in depression. This review also focuses on the effects of antidepressant drugs (e.g., monoamine antidepressants, psychotropic drugs, and N -methyl- d -aspartate receptor antagonists) on Cx43-mediated function and provides evidence for Cx43 as a novel target for the treatment of MDD. Graphical Abstract The pathogenesis of MDD is related to astrocyte dysfunction, with reduced Cx43 expression, GJ dysfunction, decreased GJIC and reduced BDNF expression in the depressed brain. The effect of Cx43 on neuroinflammation-related depression involving inflammatory cytokines, glutamate excitotoxicity, and HPA axis dysregulation. Antidepressant drugs targeting Cx43 can effectively relieve depressive symptoms.